{
    "eid": "2-s2.0-85131217314",
    "title": "Pharmacogenomics in clinical practice to prevent risperidone-induced hyperprolactinemia in autism spectrum disorder",
    "cover-date": "2022-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Genetics",
            "@code": "1311",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "autism spectrum disorder",
        "CYP2D6 and DRD2 genetic polymorphisms",
        "hyperprolactinemia",
        "pharmacogenomics",
        "precision medicine",
        "risperidone"
    ],
    "authors": [
        "Mohitosh Biswas",
        "Natchaya Vanwong",
        "Chonlaphat Sukasem"
    ],
    "citedby-count": 1,
    "ref-count": 54,
    "ref-list": [
        "Pharmacotherapy of autism spectrum disorder: Results from the randomized BAART clinical trial",
        "Clinical assessment, genetics, and treatment approaches in autism spectrum disorder (ASD)",
        "Systematic review: Recommendations for rehabilitation in ASD and ID from clinical practice guidelines",
        "The role of drugs in the treatment of autism",
        "Autism spectrum disorder",
        "Risk factors for autism spectrum disorder in the Thai population",
        "Identification, evaluation, and management of children with autism spectrum disorder",
        "Relationship between CYP2D6 genotype, activity score and phenotype in a pediatric Thai population treated with risperidone",
        "Clinical approach in autism: Management and treatment",
        "Hyperuricemia in children and adolescents with autism spectrum disorder treated with risperidone: The risk factors for metabolic adverse effects",
        "Risperidone-induced obesity in children and adolescents with autism spectrum disorder: Genetic and clinical risk factors",
        "Risperidone",
        "Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4",
        "Comparative pharmacology of risperidone and paliperidone",
        "The role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactions",
        "CYP2D6 polymorphisms and their influence on risperidone treatment",
        "Genetic polymorphisms associated with the pharmacokinetics, pharmacodynamics and adverse effects of olanzapine, aripiprazole and risperidone",
        "UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorder",
        "Risperidone: A review of its use in the treatment of bipolar mania",
        "Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents",
        "Classics in chemical neuroscience: Risperidone",
        "Long-acting risperidone: A review of its role in the treatment of bipolar disorder",
        "Biochemical profile of risperidone, a new antipsychotic",
        "Pharmacogenomics and efficacy of risperidone long-term treatment in Thai autistic children and adolescents",
        "Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogenetics",
        "Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone",
        "Pharmacogenomics factors influencing the effect of risperidone on prolactin levels in Thai pediatric patients with autism spectrum disorder",
        "Impact of pharmacogenetic markers of CYP2D6 and DRD2 on prolactin response in risperidone-treated Thai children and adolescents with autism spectrum disorders",
        "A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms",
        "Association between 8 P-glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug-induced hyperprolactinaemia",
        "Hyperprolactinemia in children and adolescents with use of risperidone: Clinical and molecular genetics aspects",
        "Genetics-based population pharmacokinetics and pharmacodynamics of risperidone in a psychiatric cohort",
        "Development and validation of liquid chromatography/tandem mass spectrometry analysis for therapeutic drug monitoring of risperidone and 9-hydroxyrisperidone in pediatric patients with autism spectrum disorders",
        "Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies",
        "Impact of risperidone on leptin and insulin in children and adolescents with autistic spectrum disorders",
        "Pharmacogenetics of risperidone and cardiovascular risk in children and adolescents",
        "Prolactin: Structure, function, and regulation of secretion",
        "Prolactin biology and laboratory measurement: An update on physiology and current analytical issues",
        "Clinical manifestations, evaluation and management of hyperprolactinemia in adolescent and young girls: A brief review",
        "Clinical and laboratory characteristics of hyperprolactinemia in children and adolescents: National survey",
        "Hyperprolactinemia in children with subclinical hypothyroidism",
        "CYP2D6 genotype analysis of a Thai population: Platform comparison",
        "Resolving discordant CYP2D6 genotyping results in Thai subjects: Platform limitations and novel haplotypes",
        "Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors",
        "Clinical pharmacogenetics implementation consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update",
        "The CYP2D6 activity score: Translating genotype information into a qualitative measure of phenotype",
        "In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles",
        "Genotype and co-medication dependent CYP2D6 metabolic activity: Effects on serum concentrations of aripiprazole, haloperidol, risperidone, paliperidone and zuclopenthixol",
        "Effect of rifampin, an inducer of CYP3A and P-glycoprotein, on the pharmacokinetics of risperidone",
        "Interactions between antiepileptic and antipsychotic drugs",
        "A comprehensive review of HLA and severe cutaneous adverse drug reactions: Implication for clinical pharmacogenomics and precision medicine",
        "Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings",
        "Pharmacogenetics of risperidone-induced insulin resistance in children and adolescents with autism spectrum disorder",
        "Pharmacogenomic study reveals new variants of drug metabolizing enzyme and transporter genes associated with steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in Thai autism spectrum disorder patients"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Liverpool",
            "@id": "60020661",
            "affilname": "University of Liverpool",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020661",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60020543",
            "affilname": "Bumrungrad International Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020543",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Rajshahi",
            "@id": "60020210",
            "affilname": "Rajshahi University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020210",
            "affiliation-country": "Bangladesh"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60015887",
            "affilname": "Faculty of Medicine Ramathibodi Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015887",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University",
        "Mahidol University"
    ]
}